<DOC>
	<DOCNO>NCT00027430</DOCNO>
	<brief_summary>This study determine whether testosterone replacement TheraDerm improve bone density , mood , sex drive , thinking , distribution body fat muscle mass woman hypopituitarism .</brief_summary>
	<brief_title>Androgen Replacement Therapy Women With Hypopituitarism</brief_title>
	<detailed_description>Patients randomize 2 group receive testosterone replacement therapy placebo . Group 1 receive 2 testosterone patch estrogen pill 12 month . Group 2 receive 2 placebo patch estrogen pill 12 month . Changes bone density , bone metabolism marker , body composition , libido , quality life compare woman receive testosterone replacement therapy woman receive placebo . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Hypopituitarism</mesh_term>
	<criteria>Inclusion criterion : Hypogonadism and/or hypoadrenalism central origin Testosterone free testosterone level median agematched normal control Prior estrogen preparation least 6 month Exclusion criterion : Any disease know affect bone metabolism , include untreated hypothyroidism hyperthyroidism Change thyroid hormone dose last 3 month Untreated Cushing 's syndrome Renal failure Alcoholism Anorexia nervosa Prior use medication know affect bone metabolism ( e.g. , supraphysiologic dos glucocorticoid , phenytoin , bisphosphonates , calcitonin ) within past 3 month Pregnant nursing Uncontrolled hypertension ALT great 3 time upper limit normal Serum creatinine great 2 time upper limit normal Any contraindication estrogen therapy , include history breast cancer undiagnosed uterine bleed Concurrent growth hormone replacement therapy , patient receive less 2 year</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2001</verification_date>
</DOC>